NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -13.20%581.8M | -4.06%221.9M | 9.56%195.9M | -59.09%57.4M | -11.09%106.6M | 71.26%670.3M | 30.90%231.3M | 11.54%178.8M | 270.18%140.3M | 626.67%119.9M |
Net income from continuing operations | -4.13%533.6M | -20.10%109.7M | -11.30%120.1M | -0.51%156.2M | 16.31%147.6M | 136.15%556.6M | 214.32%137.3M | 23.32%135.4M | 24.41%157M | 5.93%126.9M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | -100.22%-900K | --5.1M | --0 | ---- | ---- |
Depreciation and amortization | 0.64%78.8M | -7.21%19.3M | 4.64%20.3M | 3.70%19.6M | 2.08%19.6M | 1.82%78.3M | 1.96%20.8M | 6.59%19.4M | 5.00%18.9M | -5.42%19.2M |
Deferred tax | -27.78%-4.6M | -2.78%-3.7M | --600K | ---4.4M | --2.9M | 97.85%-3.6M | ---3.6M | --0 | --0 | --0 |
Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Change In working capital | -456.25%-45.6M | 24.93%89.7M | 133.78%52.6M | -255.05%-116.1M | -47.13%-71.8M | 107.04%12.8M | 175.10%71.8M | -27.18%22.5M | 69.64%-32.7M | 62.80%-48.8M |
-Change in receivables | 398.78%49M | ---- | ---- | ---- | ---- | -138.59%-16.4M | ---- | ---- | ---- | ---- |
-Change in inventory | -323.76%-40.5M | ---- | ---- | ---- | ---- | 121.86%18.1M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | -654.29%-38.8M | ---- | ---- | ---- | ---- | 105.15%7M | ---- | ---- | ---- | ---- |
-Change in other current assets | -1.39%7.1M | ---- | ---- | ---- | ---- | 179.12%7.2M | ---- | ---- | ---- | ---- |
-Change in other working capital | -622.58%-22.4M | 101.97%112.9M | 133.78%52.6M | -255.05%-116.1M | -47.13%-71.8M | -191.18%-3.1M | -73.56%55.9M | -27.18%22.5M | 69.64%-32.7M | 62.80%-48.8M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -13.20%581.8M | -4.06%221.9M | 9.56%195.9M | -59.09%57.4M | -11.09%106.6M | 71.26%670.3M | 30.90%231.3M | 11.54%178.8M | 270.18%140.3M | 626.67%119.9M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,008.30%-267.1M | -2,428.36%-156M | 21.05%-51M | -74.54%11.1M | -626.53%-71.2M | -397.53%-24.1M | 113.35%6.7M | -471.26%-64.6M | 12.37%43.6M | -566.67%-9.8M |
Capital expenditure reported | -48.76%-108M | -2.34%-30.6M | -75.68%-32.5M | -69.63%-22.9M | -105.61%-22M | -3.27%-72.6M | -54.12%-29.9M | 8.42%-18.5M | 24.16%-13.5M | 17.05%-10.7M |
Net business purchase and sale | -768.45%-145.9M | -17,700.00%-124.6M | --0 | ---200K | ---21.1M | -110.00%-16.8M | ---700K | ---16.1M | --0 | --0 |
Net investment purchase and sale | -120.21%-13.2M | -102.14%-800K | 38.33%-18.5M | -40.11%34.2M | -3,222.22%-28.1M | -24.42%65.3M | 221.10%37.3M | -179.79%-30M | -11.61%57.1M | -94.00%900K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,008.30%-267.1M | -2,428.36%-156M | 21.05%-51M | -74.54%11.1M | -626.53%-71.2M | -397.53%-24.1M | 113.35%6.7M | -471.26%-64.6M | 12.37%43.6M | -566.67%-9.8M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 40.35%-408.4M | 77.88%-40.7M | 31.26%-144M | 46.77%-103.1M | -23.69%-120.6M | -58.94%-684.7M | -66.21%-184M | -48.69%-209.5M | -57.35%-193.7M | -73.80%-97.5M |
Net issuance payments of debt | 131.96%69.7M | 2,493.75%76.6M | 71.96%-21.2M | 115.56%21.1M | -83.78%-6.8M | -244.82%-218.1M | -105.71%-3.2M | -964.79%-75.6M | -4,620.00%-135.6M | -103.75%-3.7M |
Net common stock issuance | 0.23%-305.8M | 52.65%-68.7M | 8.61%-83.9M | -376.97%-78.7M | -40.30%-74.5M | 24.04%-306.5M | -19.42%-145.1M | -0.22%-91.8M | 80.00%-16.5M | 50.79%-53.1M |
Cash dividends paid | -3.76%-190.4M | -3.56%-49.5M | -3.55%-46.7M | -3.76%-46.9M | -4.19%-47.3M | -3.56%-183.5M | -3.69%-47.8M | -4.40%-45.1M | -3.43%-45.2M | -2.71%-45.4M |
Proceeds from stock option exercised by employees | -22.65%18.1M | -92.56%900K | 160.00%7.8M | -61.11%1.4M | 70.21%8M | 3,442.86%23.4M | --12.1M | --3M | 3,500.00%3.6M | 274.07%4.7M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 40.35%-408.4M | 77.88%-40.7M | 31.26%-144M | 46.77%-103.1M | -23.69%-120.6M | -58.94%-684.7M | -66.21%-184M | -48.69%-209.5M | -57.35%-193.7M | -73.80%-97.5M |
Net cash flow | ||||||||||
Beginning cash position | -13.11%339.9M | -21.96%219.3M | -42.97%216.1M | -38.06%251.6M | -13.11%339.9M | -11.75%391.2M | -21.68%281M | 5.43%378.9M | 0.10%406.2M | -11.75%391.2M |
Current changes in cash | -143.38%-93.7M | -53.33%25.2M | 100.94%900K | -253.06%-34.6M | -776.19%-85.2M | -23.00%-38.5M | 241.77%54M | -358.97%-95.3M | 78.88%-9.8M | 133.60%12.6M |
Effect of exchange rate changes | 48.44%-6.6M | -200.00%-4.9M | 188.46%2.3M | 94.86%-900K | -229.17%-3.1M | 38.46%-12.8M | -70.48%4.9M | 93.05%-2.6M | ---17.5M | --2.4M |
End cash Position | -29.51%239.6M | -29.51%239.6M | -21.96%219.3M | -42.97%216.1M | -38.06%251.6M | -13.11%339.9M | -13.11%339.9M | -21.68%281M | 5.43%378.9M | 0.10%406.2M |
Free cash flow | -20.73%473.8M | -5.01%191.3M | 1.93%163.4M | -72.79%34.5M | -22.53%84.6M | 86.14%597.7M | 28.04%201.4M | 14.42%160.3M | 530.85%126.8M | 2,933.33%109.2M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |